Insider Trading activities of Amicus Therapeutics, Inc. (FOLD) , Part 4

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Amicus Therapeutics, Inc. since 2005. The reporting company's ticker symbol is FOLD. The reporting company's CIK number is 1178879.
The total value of stock buying since 2005 is $164,300,576.
The total value of stock sales since 2005 is $237,123,129.
The total value of stock option exercises since 2005 is $27,779,222.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Amicus Therapeutics, Inc. insiders (FOLD) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-08-04 Crowley John F (President & CEO) Sale 6,200 15.24 94,500
2008-08-04 Bloch Stephen M (Director) Sale 4,500 15.23 68,553
2008-08-01 Crowley John F (President & CEO) Sale 3,800 15.42 58,603
2008-08-01 Bloch Stephen M (Director) Sale 3,700 15.45 57,168
2008-07-31 Bloch Stephen M (Director) Sale 10,000 7,740.23 77,402,320
2008-07-30 Bloch Stephen M (Director) Sale 4,700 15.19 71,369
2008-07-29 Bloch Stephen M (Director) Sale 3,600 15.30 55,087
2008-07-28 Palling David (Senior VP, Drug Development) Sale 2,500 15.08 37,692
2008-07-28 Bloch Stephen M (Director) Sale 9,000 15.22 137,025
2008-07-25 Bloch Stephen M (Director) Sale 2,300 15.43 35,493
2008-07-24 Bloch Stephen M (Director) Sale 5,661 15.23 86,245
2008-07-23 Bloch Stephen M (Director) Sale 1,834 15.00 27,506
2008-07-22 Licholai Gregory P (VP, Medical Affairs) Sale 15,000 15.00 225,000
2008-07-22 Licholai Gregory P (VP, Medical Affairs) Option Ex 15,000 .64 9,555
2008-07-22 Bloch Stephen M (Director) Sale 8,589 15.01 128,877
2008-07-21 Bloch Stephen M (Director) Sale 7,600 14.47 109,972
2008-07-18 Bloch Stephen M (Director) Sale 10,400 13.86 144,123
2008-07-17 Bloch Stephen M (Director) Sale 1,600 13.38 21,401
2008-07-16 Bloch Stephen M (Director) Sale 1,900 13.16 25,007
2008-07-15 Licholai Gregory P (VP, Medical Affairs) Sale 15,000 13.00 195,000
2008-07-15 Licholai Gregory P (VP, Medical Affairs) Option Ex 15,000 .64 9,555
2008-07-15 Bloch Stephen M (Director) Sale 5,600 12.89 72,212
2008-07-14 Bloch Stephen M (Director) Sale 1,600 12.61 20,171
2008-07-11 Bloch Stephen M (Director) Sale 8,893 12.55 111,607
2008-07-07 Crowley John F (President and CEO) Sale 2,200 11.09 24,391
2008-07-03 Crowley John F (President and CEO) Sale 1,500 10.84 16,266
2008-07-02 Crowley John F (President and CEO) Sale 3,000 11.05 33,150
2008-07-01 Crowley John F (President and CEO) Sale 3,300 10.72 35,385
2008-06-20 Patterson Matthew R (Chief Operating Officer) Sale 1,400 11.38 15,932
2008-06-19 Patterson Matthew R (Chief Operating Officer) Sale 400 11.05 4,421
2008-06-18 Patterson Matthew R (Chief Operating Officer) Sale 1,500 11.01 16,512
2008-06-17 Patterson Matthew R (Chief Operating Officer) Sale 1,800 11.08 19,945
2008-06-16 Patterson Matthew R (Chief Operating Officer) Sale 4,900 11.18 54,801
2008-06-04 Crowley John F (President and CEO) Sale 5,000 10.43 52,130
2008-05-02 Crowley John F (President and CEO) Sale 4,795 10.45 50,088
2008-05-01 Crowley John F (President and CEO) Sale 5,205 10.59 55,141
2008-04-24 Palling David (Senior VP, Drug Development) Option Ex 20,000 .64 12,740
2008-04-16 Patterson Matthew R (Chief Operating Officer) Sale 578 10.00 5,780
2008-04-15 Patterson Matthew R (Chief Operating Officer) Sale 3,422 10.17 34,808
2008-04-14 Patterson Matthew R (Chief Operating Officer) Sale 6,000 10.61 62,987
2008-04-03 Crowley John F (President and CEO) Sale 3,600 11.03 39,690
2008-04-02 Crowley John F (President and CEO) Sale 11,600 11.04 128,028
2008-04-01 Palling David (Senior VP, Drug Development) Sale 1,250 11.14 13,931
2008-04-01 Crowley John F (President and CEO) Sale 2,400 11.10 26,632
2008-03-10 Topper James N (Director) Buy 5,500 10.21 56,668
2008-03-10 Frazier Affiliates Iv Lp (10% Owner) Buy 5,500 10.21 56,668
2008-03-06 Topper James N (Director) Buy 22,146 9.99 221,349
2008-03-06 Frazier Affiliates Iv Lp (10% Owner) Buy 22,146 9.99 221,349
2008-03-05 Topper James N (Director) Buy 50,000 9.77 490,574
2008-03-05 Frazier Affiliates Iv Lp (10% Owner) Buy 50,000 9.77 490,574
2008-03-04 Crowley John F (President and CEO) Sale 5,503 10.00 55,030
2008-03-04 Topper James N (Director) Buy 13,500 9.83 133,343
2008-03-04 Frazier Affiliates Iv Lp (10% Owner) Buy 13,500 9.83 133,343
2008-03-03 Crowley John F (President and CEO) Sale 4,497 10.00 44,970
2008-03-03 Topper James N (Director) Buy 62,100 268.09 10,124,103
2008-03-03 Frazier Affiliates Iv Lp (10% Owner) Buy 62,100 9.80 605,452
2008-02-29 Crowley John F (President and CEO) Option Ex 10,000 .64 6,380
2008-02-29 Topper James N (Director) Buy 8,637 9.88 85,333
2008-02-29 Frazier Affiliates Iv Lp (10% Owner) Buy 8,637 9.88 85,333
2008-02-28 Palling David (Senior VP, Drug Development) Sale 2,500 10.51 26,262
2008-02-28 Licholai Gregory P (VP, Medical Affairs) Sale 10,000 10.04 100,440
2008-02-28 Topper James N (Director) Buy 7,800 9.99 78,278
2008-02-28 Frazier Affiliates Iv Lp (10% Owner) Buy 7,800 9.99 78,278
2008-02-27 Topper James N (Director) Buy 23,300 9.92 230,285
2008-02-27 Frazier Affiliates Iv Lp (10% Owner) Buy 23,300 9.92 230,285
2008-02-26 Topper James N (Director) Buy 8,000 9.90 78,384
2008-02-26 Frazier Affiliates Iv Lp (10% Owner) Buy 8,000 9.90 78,384
2008-02-25 Topper James N (Director) Buy 9,700 9.66 93,731
2008-02-25 Frazier Affiliates Iv Lp (10% Owner) Buy 9,700 9.66 93,731
2008-02-22 Topper James N (Director) Buy 8,814 9.79 86,405
2008-02-22 Frazier Affiliates Iv Lp (10% Owner) Buy 8,814 9.79 86,405
2008-02-21 Patterson Matthew R (Chief Operating Officer) Option Ex 12,083 .64 7,708
2008-02-21 Topper James N (Director) Buy 5,500 10.23 56,275
2008-02-21 Frazier Affiliates Iv Lp (10% Owner) Buy 5,500 10.23 56,275
2008-02-20 Topper James N (Director) Buy 49,500 9.61 475,447
2008-02-20 Frazier Affiliates Iv Lp (10% Owner) Buy 49,500 9.61 475,447
2008-02-19 Topper James N (Director) Buy 9,600 9.90 95,059
2008-02-19 Frazier Affiliates Iv Lp (10% Owner) Buy 9,600 9.90 95,059
2008-02-15 Topper James N (Director) Buy 6,900 10.48 72,346
2008-02-15 Frazier Affiliates Iv Lp (10% Owner) Buy 6,900 10.48 72,346
2008-02-13 Topper James N (Director) Buy 12,000 10.39 124,598
2008-02-13 Frazier Affiliates Iv Lp (10% Owner) Buy 12,000 10.39 124,598
2008-02-12 Topper James N (Director) Buy 9,400 10.04 94,394
2008-02-12 Frazier Affiliates Iv Lp (10% Owner) Buy 9,400 10.04 94,394
2008-02-11 Topper James N (Director) Buy 5,700 10.05 57,267
2008-02-11 Frazier Affiliates Iv Lp (10% Owner) Buy 5,700 10.05 57,267
2008-02-08 Topper James N (Director) Buy 33,800 10.12 342,123
2008-02-08 Frazier Affiliates Iv Lp (10% Owner) Buy 33,800 10.12 342,123
2008-02-07 Topper James N (Director) Buy 25,400 10.09 256,209
2008-02-07 Frazier Affiliates Iv Lp (10% Owner) Buy 25,400 10.09 256,209
2008-02-06 Topper James N (Director) Buy 45,477 10.12 460,454
2008-02-06 Frazier Affiliates Iv Lp (10% Owner) Buy 45,477 10.12 460,454
2008-02-05 Fhm V, Llc (10% Owner) Buy 68,400 10.33 706,054
2008-02-05 Topper James N (Director) Buy 68,400 10.33 706,054
2008-02-04 Fhm V, Llc (10% Owner) Buy 59,175 10.28 609,546
2008-02-04 Topper James N (Director) Buy 59,175 10.28 609,546
2008-02-01 Palling David (Senior VP, Drug Development) Sale 3,000 10.00 30,000
2008-02-01 Crowley John F (President and CEO) Sale 10,000 10.00 100,000
2008-02-01 Licholai Gregory P (VP, Medical Affairs) Sale 10,000 9.90 99,000
2008-02-01 Fhm V, Llc (10% Owner) Buy 80,000 9.39 756,701
2008-02-01 Topper James N (Director) Buy 80,000 9.26 756,701
2008-01-31 Fhm V, Lp (10% Owner) Buy 22,885 10.00 228,850
2008-01-31 Fhm V, Llc (10% Owner) Buy 15,015 9.97 150,697
2008-01-31 Topper James N (Director) Buy 37,900 9.99 379,547
2008-01-02 Crowley John F (President and CEO) Sale 10,000 10.30 103,050
2008-01-02 Crowley John F (President and CEO) Option Ex 20,000 .64 12,760
2007-12-14 Crowley John F (President & CEO) Option Ex 5,000 .64 3,190
2007-12-13 Crowley John F (President & CEO) Option Ex 10,000 .64 6,380
2007-08-24 Sblendorio Glenn (Director) Buy 1,000 11.42 11,420
2007-08-15 Patterson Matthew R (Chief Operating Officer) Option Ex 32,366 .64 20,649
2007-08-08 Fhm V, Llc (10% Owner) Buy 29,600 11.50 340,400
2007-08-08 Topper James N (Director) Buy 29,600 11.50 340,400
2007-07-27 Fhm V, Llc (10% Owner) Buy 17,800 11.37 202,332
2007-07-27 Topper James N (Director) Buy 17,800 11.37 202,332
2007-07-26 Fhm V, Llc (10% Owner) Buy 8,000 11.39 91,113
2007-07-26 Topper James N (Director) Buy 8,000 11.39 91,113
2007-07-25 Fhm V, Llc (10% Owner) Buy 29,700 11.42 339,174
2007-07-25 Topper James N (Director) Buy 29,700 11.42 339,174
2007-06-29 Topper James N (Director) Buy 13,900 11.46 159,224
2007-06-29 Frazier Healthcare Iv Lp (10% Owner) Buy 13,900 11.46 159,224
2007-06-28 Topper James N (Director) Buy 9,015 11.44 103,127
2007-06-28 Frazier Healthcare Iv Lp (10% Owner) Buy 4,281 11.49 49,188
2007-06-27 Topper James N (Director) Buy 144,400 11.22 1,624,742
2007-06-21 Crowley John F (President & CEO) Option Ex 33,736 .64 21,523
2007-06-05 Trainor Iii Eugene A (10% Owner) Sale 6,408 15.00 96,120
2007-06-05 Hirsch Russell C (10% Owner) Sale 6,427 15.00 96,405
2007-06-05 Barkas Alexander E (Director) Sale 6,427 15.00 96,405
2007-06-05 Perry Mark W (10% Owner) Sale 6,408 15.00 96,120
2007-06-05 Barris Peter J (10% Owner) Sale 6,408 15.00 96,120
2007-06-05 Kramlich C Richard (10% Owner) Sale 6,408 15.00 96,120
2007-06-05 Newhall Charles W Iii (10% Owner) Sale 6,408 15.00 96,120
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month